Aravis
VC · Zurich (Switzerland)
Sign up free to access full profile and submit your pitch.
About
Aravis SA is a private equity and venture capital firm specializing in investments in seed/startups, early-stage, expansion, growth and development capital, mature, late venture , later stage , buyout, spin-off, and turnaround investments. It seeks to invest in companies needing seed financing up to companies with early and late stage preclinical development. The firm prefers to invest in life sciences, renewable energy, and luxury goods sector. Within energy, the firm seeks to invest in companies that produce renewable energy from wind, solar and water. Within life sciences, it focuses on biopharmaceutical, healthcare technology, medical technology, life sciences tools and services, biotechnology, and on companies developing break-through technologies or working in the therapeutic area of immunology, inflammation, oncology, and CNS. Within the luxury sector it focuses on accessories, including leather goods, shoes, and jewellery. It seeks to invest in Swiss life sciences companies based in Europe, Asia, United States, and Canada and those renewable energy companies based in Europe. In the luxury sector it seeks to invest in emerging and declining mid-size companies in Europe and emerging companies in Asia. It invests in companies based in Caribbean, Central America, and Mexico. The firm typically invests between CHF 0.67 million ($0.7 million) and CHF 10 million ($9.64 million) in companies and an investment size between CHF 7 million ($6.75 million) and CHF 10 million ($9.64 million). It seeks to take an equity stake between 15 percent and 20 percent in its portfolio companies. The firm takes controlling and leading positions and exits its investments within five years through reverse take-overs, IPO’s, listings, and trade sale. Aravis SA was founded in 2001 and is headquartered in Zurich, Switzerland with additional offices in Laax, Switzerland and Menlo Park, California.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.